PDF(Pubmed)
Abstract：
Here, we present a case of relapsing-remitting multiple sclerosis that experienced petechiae and epistaxis following treatment with second dose of alemtuzumab. This study highlights such effects, emphasizing the need for vigilance as alemtuzumab usage increases. Timely recognition and management are vital for patient care.
摘要：
这里,我们介绍了一例复发-缓解型多发性硬化病例,在使用第二剂阿仑单抗治疗后出现瘀点和鼻出血.这项研究强调了这种影响，强调随着阿仑单抗使用量的增加，需要保持警惕。及时的识别和管理对于患者护理至关重要。
